
Jan 12, 2025, 07:53
Ponsegromab as a novel, targeted therapy to address unmet needs of patients with cancer and cachexia
ACS Journal Cancer shared on X:
“In the latest Cancer Scope, attention is given to promising findings recently published in NEJM, which show the potential for ponsegromab as a novel, targeted therapy to address unmet needs of patients with cancer and cachexia.”
Authors: Mary Beth Nierengarten
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 27, 2025, 04:23
Jul 27, 2025, 04:16
Jul 27, 2025, 03:59
Jul 27, 2025, 03:44
Jul 27, 2025, 01:55
Jul 26, 2025, 21:46
Jul 26, 2025, 21:30
Jul 26, 2025, 21:09
Jul 26, 2025, 20:53
Jul 26, 2025, 20:13